Bluejay Diagnostics (BJDX) Competitors

Bluejay Diagnostics logo
$3.42 -0.17 (-4.71%)
As of 02:24 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BJDX vs. PSTV, STRR, CTCX, NUWE, CHEK, TNON, SINT, TTOO, HSCS, and AMIX

Should you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include Plus Therapeutics (PSTV), Star Equity (STRR), Carmell (CTCX), Nuwellis (NUWE), Check-Cap (CHEK), Tenon Medical (TNON), Sintx Technologies (SINT), T2 Biosystems (TTOO), Heart Test Laboratories (HSCS), and Autonomix Medical (AMIX). These companies are all part of the "medical equipment" industry.

Bluejay Diagnostics vs.

Bluejay Diagnostics (NASDAQ:BJDX) and Plus Therapeutics (NASDAQ:PSTV) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, community ranking, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

Bluejay Diagnostics has a net margin of 0.00% compared to Plus Therapeutics' net margin of -225.07%. Plus Therapeutics' return on equity of 0.00% beat Bluejay Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Bluejay DiagnosticsN/A -155.67% -117.82%
Plus Therapeutics -225.07%N/A -154.56%

18.5% of Bluejay Diagnostics shares are owned by institutional investors. Comparatively, 3.3% of Plus Therapeutics shares are owned by institutional investors. 0.4% of Bluejay Diagnostics shares are owned by insiders. Comparatively, 5.5% of Plus Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Plus Therapeutics received 66 more outperform votes than Bluejay Diagnostics when rated by MarketBeat users. However, 66.67% of users gave Bluejay Diagnostics an outperform vote while only 62.39% of users gave Plus Therapeutics an outperform vote.

CompanyUnderperformOutperform
Bluejay DiagnosticsOutperform Votes
2
66.67%
Underperform Votes
1
33.33%
Plus TherapeuticsOutperform Votes
68
62.39%
Underperform Votes
41
37.61%

Bluejay Diagnostics has higher earnings, but lower revenue than Plus Therapeutics. Plus Therapeutics is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bluejay Diagnostics$250K7.53-$9.95M-$1.37 thousand0.00
Plus Therapeutics$4.91M1.44-$13.32M-$2.53-0.47

Bluejay Diagnostics has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500. Comparatively, Plus Therapeutics has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500.

In the previous week, Bluejay Diagnostics and Bluejay Diagnostics both had 1 articles in the media. Plus Therapeutics' average media sentiment score of 0.00 beat Bluejay Diagnostics' score of -1.00 indicating that Plus Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Bluejay Diagnostics Negative
Plus Therapeutics Neutral

Plus Therapeutics has a consensus target price of $13.50, indicating a potential upside of 1,025.00%. Given Plus Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Plus Therapeutics is more favorable than Bluejay Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bluejay Diagnostics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Plus Therapeutics
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Plus Therapeutics beats Bluejay Diagnostics on 10 of the 17 factors compared between the two stocks.

Get Bluejay Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BJDX vs. The Competition

MetricBluejay DiagnosticsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.88M$4.68B$5.76B$9.17B
Dividend YieldN/A47.50%5.25%3.99%
P/E Ratio0.0025.4226.1019.46
Price / Sales7.5361.70456.3571.26
Price / CashN/A50.3946.0638.90
Price / Book0.006.527.305.06
Net Income-$9.95M$89.44M$3.19B$222.54M
7 Day Performance-6.27%2.05%2.22%2.30%
1 Month Performance2.12%1.92%3.57%1.62%
1 Year Performance-98.92%18.34%21.26%16.61%

Bluejay Diagnostics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BJDX
Bluejay Diagnostics
0.2133 of 5 stars
$3.42
-4.7%
N/A-98.9%$1.88M$250,000.000.009Short Interest ↑
Negative News
PSTV
Plus Therapeutics
2.2432 of 5 stars
$1.22
-1.3%
$13.50
+1,006.5%
-38.0%$7.20M$4.91M-0.4820News Coverage
Gap Down
STRR
Star Equity
1.1004 of 5 stars
$2.11
+2.4%
N/A-54.6%$6.79M$45.78M-0.82460
CTCX
Carmell
1.7992 of 5 stars
$0.28
-9.2%
N/A-93.3%$5.90MN/A0.0014Positive News
NUWE
Nuwellis
2.4174 of 5 stars
$1.33
+4.7%
$17.00
+1,178.2%
-93.9%$5.81M$8.86M-0.0170Gap Up
CHEK
Check-Cap
0.963 of 5 stars
$0.90
-2.2%
N/A-59.8%$5.27MN/A-0.3080
TNON
Tenon Medical
1.6204 of 5 stars
$1.46
-2.3%
$5.50
+278.0%
+19.7%$4.57M$2.93M-0.058
SINT
Sintx Technologies
0.6143 of 5 stars
$3.06
-5.6%
N/A-89.8%$4.10M$2.63M-0.0640Gap Down
TTOO
T2 Biosystems
1.7701 of 5 stars
$0.19
-7.4%
$5.00
+2,472.0%
-98.9%$4.09M$7.68M0.00180News Coverage
Gap Up
High Trading Volume
HSCS
Heart Test Laboratories
3.3673 of 5 stars
$3.59
-5.5%
$13.50
+276.0%
-69.1%$3.52M$20,000.00-0.4510Short Interest ↓
Gap Up
AMIX
Autonomix Medical
2.5936 of 5 stars
$2.72
+0.7%
$28.00
+929.4%
-96.2%$3.13MN/A-0.171Earnings Report

Related Companies and Tools


This page (NASDAQ:BJDX) was last updated on 2/18/2025 by MarketBeat.com Staff
From Our Partners